News

BACK

Life Sciences

Rare vs common Diseases: main differences in the pharmaceutical world Rare vs common Diseases: main differences in the pharmaceutical world Sara, ALTEN’s Life Sciences and Medical Affairs Consultant, tells us about the differences that exist between rare and common diseases. Rare diseases are often genetic, chronic and progressive. These diseases…
European Medicines Agency (EMA) restricts quinolones and fluoroquinolones antibiotics European Medicines Agency (EMA) restricts quinolones and fluoroquinolones antibiotics María is a pharmacovigilance expert and a Life Sciences’ Consultant at ALTEN. In this article she talks about the potential risks of using quinolones and fluoroquinolones antibiotics. What is the…
Advanced therapy medicinal products Advanced therapy medicinal products Roman is a Medical Affairs’ expert and a consultant in the Life Sciences Division at ALTEN. In the following article, he explains everything about innovative medicines. What are the advanced…
More news

Corporate

Business grows sharply in first half 2019: +17.5% Business grows sharply in first half 2019: +17.5% Strong organic growth: +12.5% 6 acquisitions outside France SHARP GROWTH IN ACTIVITY AS AT END OF JUNE 2019: +17.5% Following on the growth of 2018, business has remained very bullish…
Business at the end of December 2018 Business at the end of December 2018 Sharp growth of activity: +14.4% Strong organic growth: +12% 10 international acquisitions Business up +14.4% at end of December Business continued to grow all through 2018 both in France (+11.3%)…
Engineering outsourcing in the automotive industry Engineering outsourcing in the automotive industry During the 90’s, the Portuguese economy experienced a huge boost related with Telco Providers and Financial institutions. This reality acted as enabler for the growth of outsourcing activities related with…
More news